Oncotarget

Research Papers:

C-MYC and BCL-2 mediate YAP-regulated tumorigenesis in OSCC

Xiyan Chen, Weiting Gu, Qi Wang, Xucheng Fu, Ying Wang, Xin Xu and Yong Wen _

PDF  |  HTML  |  How to cite

Oncotarget. 2018; 9:668-679. https://doi.org/10.18632/oncotarget.23089

Metrics: PDF 1967 views  |   HTML 2754 views  |   ?  


Abstract

Xiyan Chen1,2,*, Weiting Gu3,*, Qi Wang1,2, Xucheng Fu1,2, Ying Wang1,2, Xin Xu1,2 and Yong Wen1,2

1School of Stomatology, Shandong University, Jinan, China

2Shandong Provincial Key Laboratory of Oral Tissue Regeneration, Jinan, China

3Qilu Hospital of Shandong University, Jinan, China

*These authors contributed equally to this work

Correspondence to:

Yong Wen, email: [email protected]

Keywords: yes-associated protein(YAP); oral squamous cell carcinoma (OSCC); C-MYC; BCL-2; tumorigenesis

Received: August 20, 2017     Accepted: November 17, 2017     Published: December 07, 2017

ABSTRACT

Transcriptional co-activator Yes-associated protein (YAP) is a key oncogene in mammalian cells. The present understanding of YAP in oral squamous cells carcinoma (OSCC) remains unclear. The purpose of this study is to investigate the effects of YAP on proliferation and apoptosis in OSCC and the molecular mechanism. The results showed the expression level of YAP was higher in OSCC tissues than that in adjacent normal tissues. Knockdown of YAP in CAL27 cell lines prohibited cell proliferation while augmented apoptosis. Conversely, overexpression of YAP protected cells from apoptosis and promoted cell proliferation. Moreover, C-MYC and BCL-2 mRNA and protein levels were altered due to the differential expression of YAP. Subsequent Verteporfin treatment in CAL27 cells revealed that the transcription and translation of BCL-2 and C-MYC both decreased. In a tumor xenograft model, knockdown of YAP suppressed tumor growth of CAL27 in vivo, while YAP overexpression promoted the tumor growth. These results suggest that YAP is a crucial regulator that exerts pro-proliferation and anti-apoptosis effects in OSCC through actions affecting the cell cycle and intrinsic apoptotic signaling. Thus YAP could potentially serve as a valuable molecular biomarker or therapeutic target in the treatment of OSCC.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23089